SciLifeLab Anubis

Three Research Environment and Development (RED) Postdoctoral Fellowship grants are open for applications in 2023. RED Postdoc Fellows will receive a 2-year contract (1 MSEK/yr) to work on self-designed research projects. Successful candidates will be matched to an existing research group and embedded in the unique interdisciplinary and collaborative research environment at SciLifeLab Campus Solna.

SciLifeLab is a research infrastructure in Sweden with unique technologies and broad expertise in molecular life sciences. Campus Solna is jointly operated by the Royal Institute of Technology (KTH), Karolinska Institutet (KI) and Stockholm University (SU), also known as Stockholm Trio. All activities at Campus Solna are aligned with its dual mission: hosting national research infrastructures, and being an internationally competitive research center. Technical innovations developed at Campus Solna, enhance SciLifeLab's reputation at the forefront of molecular life sciences.

Research at Campus Solna is supported by expert staff scientists and state-of-the-art experimental facilities that together provide a unique environment for training scientists at all career stages.

The SciLifeLab and Wallenberg National Program for Data-Driven Life Science (DDLS) is a 12-year initiative funded with a total of 3,1 billion SEK from the Knut and Alice Wallenberg Foundation. The purpose of the program is to recruit and train the next-generation of data-driven life scientists and to create globally leading computational and data science capabilities in life science in Sweden.

One part of the program is to establish a research school for 260 PhDs, within both academia and industry. The aim of the DDLS Research School is to educate highly skilled and competent professionals who will make a significant contribution to the field of life science research in Sweden.

The PhD students will be recruited to a host university/organization in Sweden, aiming to link them up with strong local research environments as well as with the national DDLS program.

As the PhD candidates are recruited at a host university in Sweden, they will be enrolled as members of the DDLS Research School and expected to take part in the DDLS Research School activities (networking events, courses, scientific visits, etc.).

The DDLS program will focus on four strategic areas of data-driven research: cell and molecular biology, evolution and biodiversity, precision medicine and diagnostics, epidemiology and biology of infection.

The SciLifeLab and Wallenberg National Program for Data-Driven Life Science (DDLS) is a 12-year initiative funded with a total of 3,1 billion SEK from the Knut and Alice Wallenberg Foundation. The purpose of the program is to recruit and train the next-generation of data-driven life scientists and to create globally leading computational and data science capabilities in life science in Sweden.

DDLS will establish a research school for 260 PhDs, with two components, one focussing on academic PhD students and one for industrial PhD students. The aim of the DDLS Research School is to educate highly skilled and competent professionals who will make a significant contribution to the field of life science research in Sweden.

The industrial PhD students will be employed or recruited to a company in the life science sector in Sweden, aiming to link them up with strong local research environments at universities as well as with the national DDLS program. The admission process and training will take place at the participating Universities.

As the PhD candidates are admitted to a host University in Sweden, they will be enrolled as members of the DDLS Research School and are expected to take part in the DDLS Research School activities (networking events, courses, scientific visits, etc.).

The DDLS program will focus on four strategic areas of data-driven research: cell and molecular biology, evolution and biodiversity, precision medicine and diagnostics, epidemiology and biology of infection.

The DDD platform at SciLifeLab supports academic drug discovery project with expertise and technical capabilities. We have, for example, platforms to develop small molecule drugs, therapeutic antibodies, oligonucleotide therapeutics, proximity-inducing agents such as bispecific antibodies and PROTACs.

In this call, the Drug Discovery and Development Platform (DDD) at SciLifeLab is looking for new pilot project proposals for drug discovery. All therapeutic modalities outlined above are of interest. Of special interest are new project ideas for (multispecific) biologics, and in collaboration with ENABLE2 https://www.ilk.uu.se/enable2/, small molecule projects for discovery of new antibiotics.

Note that small projects for selections in phage display libraries for antibodies, selections in DNA encoded chemical libraries for small molecules or limited screening for antisense or siRNA molecules can be considered.

A description of new modalities in drug discovery research can be found here: https://pubs.acs.org/doi/10.1021/acsmedchemlett.9b00582

If you have questions about the call please contact DDD by email (dddprojectproposal@scilifelab.se). This call is open for scientists with a doctoral degree at a Swedish university or higher institution. English should be used when filling out this application. You are responsible for ensuring that the application is complete. Incomplete applications will not be processed.